Zai Lab sees profits on the horizon as commercialization accelerates
The innovative drug maker’s loss narrowed last year, as it forecast potential profitability as soon as 2025 on fast-growing revenues Key Takeaways: Zai Lab is set to reach several product…
Recent Articles
RELATED ARTICLES
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK -
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Everest reaches new heights on growing drug sales
1952.HK
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
